Detail page

Knowledge Web

Person

Björn Falkenburger (1974-)

Arzt

Name	Björn Falkenburger
Time	1974- (Date of birth and death)
Place	Deutschland
Gender	männlich
Academic degree	Prof. Dr. med.
Profession	Arzt (characteristic profession) Neurologe Hochschullehrer
Variant	Björn Henrik Falkenburger (vollständiger Name) Björn H. Falkenburger B. H. Falkenburger Björn Henrik Falkenburger
Related	Universitätsklinikum Aachen. Klinik für Neurologie
Further information	Professor an der Klinik für Neurologie, Uniklinik RWTH Aachen; 2017 Habilitation an der RWTH Aachen, Medizinische Fakultät; 2002 Promotion, Medizinische Fakultät der Universität Tübingen
Record type	Person
GND-Identifier	124247245
Record ID	124247245
Involved in show all Application of IVDr NMR spectroscopy to stratify Parkinson’s disease with absolute quantitation of blood serum metabolites and lipoproteins Predictive modeling to uncover Parkinson’s disease characteristics that delay diagnosis Recursive seed amplification detects distinct α-synuclein strains in cerebrospinal fluid of patients with Parkinson’s disease A Short Cognitive and Neuropsychiatric Assessment Scale for Progressive Supranuclear Palsy A Short Cognitive and Neuropsychiatric Assessment Scale for Progressive Supranuclear Palsy Corrigendum to "Headspace solid-phase microextraction-gas chromatography-mass spectrometry for the determination of volatile and semi-volatile substances in sebum as biomarkers for Parkinson's disease" [Microchem. J. 215 (2025) 114369] Entwicklung und Validierung eines Fragebogens zur Erfassung der Sturzfrequenz bei Parkinsonerkrankten Hand- und Fingerbeugekraftmessungen als sensitiver Funktionsparameter bei Kindern und Erwachsenen mit Spinaler Muskelatrophie unter Therapie mit Nusinersen Headspace solid-phase microextraction-gas chromatography-mass spectrometry for the determination of volatile and semi-volatile substances in sebum as biomarkers for Parkinson's disease Kinetic parameters of alpha‑synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disorders SMN Protein Heterogeneity Drives Intrinsic Motor Neuron Vulnerability through Survival and Activity Related Pathways GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA) Risk willingness in multiple system atrophy and Parkinson’s disease understanding patient preferences Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS Exploring the lived experiences of individuals with Parkinson’s disease and their relatives: insights into care provision experiences, disease management support, self-management strategies, and future needs in Germany (qualitative study) Progression subtypes in Parkinson’s disease identified by a data-driven multi cohort analysis Wie die Umsetzung einer Schule für Menschen mit Parkinson-Krankheit gelingen kann – Ergebnisse eines Konsensusverfahrens und einer formativen Evaluation Serum neurofilament indicates accelerated neurodegeneration and predicts mortality in late-stage Parkinson’s disease Adaptive changes in striatal projection neurons explain the long duration response and the emergence of dyskinesias in patients with Parkinson’s disease : Neurology and Preclinical Neurological Studies - Review Article Developing assays to characterize the effects of LRRK2 G2019S on axonal lysosomes Development and Validation of a Fall Questionnaire for Patients with Parkinson’s Disease Examining FYCO1 as a modulator of autophagy for alpha-synuclein aggregate clearance in hiPSC derived neurons Gentherapie der Huntington-Krankheit Glial fibrillary acidic protein in cerebrospinal fluid of patients with spinal muscular atrophy Progredienzangst und psychosoziale Belastungsfaktoren bei Patient*innen mit idiopathischen Parkinsonsnydrom Serum neurofilament indicates that DBS surgery can cause neuronal damage whereas stimulation itself does not Versorgungssituation von Parkinson-Patienten in Sachsen : Eine sekundärdatenbasierte Analyse der Inanspruchnahme im Beobachtungszeitraum 2011 bis 2019 Wie die Umsetzung einer Schule für Menschen mit Parkinson-Krankheit gelingen kann – Ergebnisse eines Konsensusverfahrens und einer formativen Evaluation The heterogeneity of Parkinson’s disease Gentherapie der Huntington-Krankheit Cellular plasticity upon proton irradiation determines tumor cell radiosensitivity GBA-associated PD: chances and obstacles for targeted treatment strategies Adaptive changes in striatal projection neurons explain the long duration response and the emergence of dyskinesias in patients with Parkinson’s disease Versorgungssituation von Parkinson-Patienten in Sachsen : Eine sekundärdatenbasierte Analyse der Inanspruchnahme im Beobachtungszeitraum 2011 bis 2019 Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy A β-Wrapin Targeting the N-Terminus of α-Synuclein Monomers Reduces Fibril-Induced Aggregation in Neurons Markierungsfreies optisches Monitoring neuraler Regeneration und therapeutischer Intervention im Axolotl Rab7 reduces alpha-synuclein toxicity in rats and primary neurons Emotional well-being and pain could be a greater determinant of quality of life compared to motor severity in cervical dystonia Molecular mechanisms of neural stem cell plasticity and neuro-regeneration in an Alzheimer’s-like neurodegeneration model of adult zebrafish In vivo protein complementation demonstrates presynaptic α-Synuclein oligomerization and age-dependent accumulation of 8–16-mer oligomer species Signaling by plasma membrane receptors and phospholipids in neurologic diseases Wearable sensor-based objective assessment of motor symptoms in Parkinson’s disease Freisetzung von Dopamin aus Dendriten dopaminerger Neurone der Substantia nigra durch den Dopamin-Transporter Freisetzung von Dopamin aus Dendriten dopaminerger Neurone der Substantia nigra durch den Dopamin-Transporter

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Björn Falkenburger (1974-)

Application of IVDr NMR spectroscopy to stratify Parkinson’s disease with absolute quantitation of blood serum metabolites and lipoproteins

Predictive modeling to uncover Parkinson’s disease characteristics that delay diagnosis

Recursive seed amplification detects distinct α-synuclein strains in cerebrospinal fluid of patients with Parkinson’s disease

A Short Cognitive and Neuropsychiatric Assessment Scale for Progressive Supranuclear Palsy

A Short Cognitive and Neuropsychiatric Assessment Scale for Progressive Supranuclear Palsy

Corrigendum to "Headspace solid-phase microextraction-gas chromatography-mass spectrometry for the determination of volatile and semi-volatile substances in sebum as biomarkers for Parkinson's disease" [Microchem. J. 215 (2025) 114369]

Entwicklung und Validierung eines Fragebogens zur Erfassung der Sturzfrequenz bei Parkinsonerkrankten

Hand- und Fingerbeugekraftmessungen als sensitiver Funktionsparameter bei Kindern und Erwachsenen mit Spinaler Muskelatrophie unter Therapie mit Nusinersen

Headspace solid-phase microextraction-gas chromatography-mass spectrometry for the determination of volatile and semi-volatile substances in sebum as biomarkers for Parkinson's disease

Kinetic parameters of alpha‑synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disorders

SMN Protein Heterogeneity Drives Intrinsic Motor Neuron Vulnerability through Survival and Activity Related Pathways

GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA)

Risk willingness in multiple system atrophy and Parkinson’s disease understanding patient preferences

Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS

Exploring the lived experiences of individuals with Parkinson’s disease and their relatives: insights into care provision experiences, disease management support, self-management strategies, and future needs in Germany (qualitative study)

Progression subtypes in Parkinson’s disease identified by a data-driven multi cohort analysis

Wie die Umsetzung einer Schule für Menschen mit Parkinson-Krankheit gelingen kann – Ergebnisse eines Konsensusverfahrens und einer formativen Evaluation

Serum neurofilament indicates accelerated neurodegeneration and predicts mortality in late-stage Parkinson’s disease

Adaptive changes in striatal projection neurons explain the long duration response and the emergence of dyskinesias in patients with Parkinson’s disease : Neurology and Preclinical Neurological Studies - Review Article

Developing assays to characterize the effects of LRRK2 G2019S on axonal lysosomes

Development and Validation of a Fall Questionnaire for Patients with Parkinson’s Disease

Examining FYCO1 as a modulator of autophagy for alpha-synuclein aggregate clearance in hiPSC derived neurons

Gentherapie der Huntington-Krankheit

Glial fibrillary acidic protein in cerebrospinal fluid of patients with spinal muscular atrophy

Progredienzangst und psychosoziale Belastungsfaktoren bei Patient*innen mit idiopathischen Parkinsonsnydrom

Serum neurofilament indicates that DBS surgery can cause neuronal damage whereas stimulation itself does not

Versorgungssituation von Parkinson-Patienten in Sachsen : Eine sekundärdatenbasierte Analyse der Inanspruchnahme im Beobachtungszeitraum 2011 bis 2019

Wie die Umsetzung einer Schule für Menschen mit Parkinson-Krankheit gelingen kann – Ergebnisse eines Konsensusverfahrens und einer formativen Evaluation

The heterogeneity of Parkinson’s disease

Gentherapie der Huntington-Krankheit

Cellular plasticity upon proton irradiation determines tumor cell radiosensitivity

GBA-associated PD: chances and obstacles for targeted treatment strategies

Adaptive changes in striatal projection neurons explain the long duration response and the emergence of dyskinesias in patients with Parkinson’s disease

Versorgungssituation von Parkinson-Patienten in Sachsen : Eine sekundärdatenbasierte Analyse der Inanspruchnahme im Beobachtungszeitraum 2011 bis 2019

Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy

A β-Wrapin Targeting the N-Terminus of α-Synuclein Monomers Reduces Fibril-Induced Aggregation in Neurons

Markierungsfreies optisches Monitoring neuraler Regeneration und therapeutischer Intervention im Axolotl

Rab7 reduces alpha-synuclein toxicity in rats and primary neurons

Emotional well-being and pain could be a greater determinant of quality of life compared to motor severity in cervical dystonia

Molecular mechanisms of neural stem cell plasticity and neuro-regeneration in an Alzheimer’s-like neurodegeneration model of adult zebrafish

In vivo protein complementation demonstrates presynaptic α-Synuclein oligomerization and age-dependent accumulation of 8–16-mer oligomer species

Signaling by plasma membrane receptors and phospholipids in neurologic diseases

Wearable sensor-based objective assessment of motor symptoms in Parkinson’s disease

Freisetzung von Dopamin aus Dendriten dopaminerger Neurone der Substantia nigra durch den Dopamin-Transporter

Freisetzung von Dopamin aus Dendriten dopaminerger Neurone der Substantia nigra durch den Dopamin-Transporter